DK1634955T3 - Konditionale genvektorer, der er reguleret i cis - Google Patents

Konditionale genvektorer, der er reguleret i cis

Info

Publication number
DK1634955T3
DK1634955T3 DK04021854T DK04021854T DK1634955T3 DK 1634955 T3 DK1634955 T3 DK 1634955T3 DK 04021854 T DK04021854 T DK 04021854T DK 04021854 T DK04021854 T DK 04021854T DK 1634955 T3 DK1634955 T3 DK 1634955T3
Authority
DK
Denmark
Prior art keywords
cis
conditional gene
vector system
gene vectors
present
Prior art date
Application number
DK04021854T
Other languages
Danish (da)
English (en)
Inventor
Wolfgang Hammerschmidt
Sibille Humme
Dagmar Pich
Aloys Schepers
Original Assignee
Gsf Forschungszentrum Umwelt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gsf Forschungszentrum Umwelt filed Critical Gsf Forschungszentrum Umwelt
Application granted granted Critical
Publication of DK1634955T3 publication Critical patent/DK1634955T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2820/00—Vectors comprising a special origin of replication system
    • C12N2820/002—Vectors comprising a special origin of replication system inducible or controllable
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2820/00—Vectors comprising a special origin of replication system
    • C12N2820/60—Vectors comprising a special origin of replication system from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C12N2830/003—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor tet inducible

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK04021854T 2004-09-14 2004-09-14 Konditionale genvektorer, der er reguleret i cis DK1634955T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04021854A EP1634955B1 (de) 2004-09-14 2004-09-14 In cis regulierte konditionelle Genvektoren

Publications (1)

Publication Number Publication Date
DK1634955T3 true DK1634955T3 (da) 2008-03-17

Family

ID=34926537

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04021854T DK1634955T3 (da) 2004-09-14 2004-09-14 Konditionale genvektorer, der er reguleret i cis

Country Status (7)

Country Link
US (1) US7803617B2 (de)
EP (2) EP1634955B1 (de)
AT (1) ATE378415T1 (de)
DE (1) DE602004010112T2 (de)
DK (1) DK1634955T3 (de)
ES (1) ES2297315T3 (de)
WO (1) WO2006029831A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
ES2411962T3 (es) 2003-10-24 2013-07-09 Gencia Corporation Métodos y composiciones para suministrar polinucleótidos
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19635568C1 (de) * 1996-09-02 1998-03-26 Gsf Forschungszentrum Umwelt Vektorsysteme zur konditionalen Genexpression
IT1302403B1 (it) * 1998-11-06 2000-09-05 Angeletti P Ist Richerche Bio Cellule per la produzione di vettori adenovirali difettivi, metodoper la loro preparazione e loro uso.
US7723102B2 (en) * 2000-09-28 2010-05-25 Bayer Corporation Enhanced transfection system

Also Published As

Publication number Publication date
EP1799834A1 (de) 2007-06-27
EP1634955B1 (de) 2007-11-14
WO2006029831A1 (en) 2006-03-23
ATE378415T1 (de) 2007-11-15
EP1634955A1 (de) 2006-03-15
ES2297315T3 (es) 2008-05-01
US7803617B2 (en) 2010-09-28
US20070184028A1 (en) 2007-08-09
DE602004010112D1 (de) 2007-12-27
DE602004010112T2 (de) 2008-09-18

Similar Documents

Publication Publication Date Title
ATE482724T1 (de) Pegylierte glp-1-verbindungen
IL172506A0 (en) New biological entities and the use thereof
DK1639013T3 (da) Pan-kir2dl-nk-receptor-antistoffer og anvendelse heraf til diagnosticering og terapi
MX2007007602A (es) Agonistas del peptido 1 similar al glucagon, composiciones, metodos y usos.
ATE524554T1 (de) Nicht integrativer und nicht replikativer lentivirus, herstellung und verwendungen
IL226857A (en) Recombinant proteins that underwent glycosylation at site n correspond to prokaryotes
GEP20146056B (en) Acylated glucagon analogues
TW200611910A (en) Interferon-alpha polypeptides and conjugates
WO2007008486A3 (en) Aav vectors encoding superoxide dismutase
WO2009046464A8 (en) Articular cartilage gene therapy with recombinant vector encoding bmp-7
UA95446C2 (ru) Мутаци в генах oas1
DK1634955T3 (da) Konditionale genvektorer, der er reguleret i cis
DE60233756D1 (de) Vektorvermittelte organellentransfektion
WO2005034876A3 (en) Use of cell lines to produce active therapeutic proteins
DK1147134T3 (da) Hidtil ukendte kaliumkanaler og gener, der koder for disse kaliumkanaler
WO2006122971A3 (en) Treatment of disease using an improved regulated expression system
WO2006136374A3 (en) Use of gip and/or vitamin d3 analogues thereof for enhancing stem or progenitor cell differentiation into insulin producing cells
TW200621718A (en) Novel co-crystals
SG146640A1 (en) Isolated photoprotein mtclytin, and use thereof
ATE338826T1 (de) Rekombinante virale vektoren zur tetracyclinregulierbaren genexpression
TW200716749A (en) Interferon-beta gene therapy using an improved, regulated expression system
GB0616061D0 (en) Peptides and uses thereof
WO2008014470A3 (en) Adult sertoli cells and uses thereof
GB0423126D0 (en) Protein
TW200617021A (en) Isolated photoprotein aequorin y89f, and its use